43 related articles for article (PubMed ID: 21306774)
1. The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery.
Yao HJ; Ju RJ; Wang XX; Zhang Y; Li RJ; Yu Y; Zhang L; Lu WL
Biomaterials; 2011 Apr; 32(12):3285-302. PubMed ID: 21306774
[TBL] [Abstract][Full Text] [Related]
2. A simple reduction-sensitive micelles co-delivery of paclitaxel and dasatinib to overcome tumor multidrug resistance.
Li J; Xu R; Lu X; He J; Jin S
Int J Nanomedicine; 2017; 12():8043-8056. PubMed ID: 29138561
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Antitumor Effects on Drug-Resistant Breast Cancer of Paclitaxel/Lapatinib Composite Nanocrystals.
Wang J; Lv FM; Wang DL; Du JL; Guo HY; Chen HN; Zhao SJ; Liu ZP; Liu Y
Molecules; 2020 Jan; 25(3):. PubMed ID: 32019194
[TBL] [Abstract][Full Text] [Related]
4. Self-assembled nanomicelles for oral delivery of luteolin utilizing the intestinal lymphatic pathway to target pancreatic cancer.
Karole A; Dinakar YH; Sagar P; Mudavath SL
Nanoscale; 2024 Apr; 16(15):7453-7466. PubMed ID: 38517408
[TBL] [Abstract][Full Text] [Related]
5. Correction: Suppression of B7-H7 Enhanced MCF-7 Cancer Cell Line's Chemosensitivity to Paclitaxel.
Taghavi BA; Salehi M; Mokhtarzadeh A; Baradaran B
Mol Biotechnol; 2024 May; ():. PubMed ID: 38795289
[No Abstract] [Full Text] [Related]
6. Formulation development of lipid polymer hybrid nanoparticles of doxorubicin and its
Shafique M; Ur Rehman M; Kamal Z; Alzhrani RM; Alshehri S; Alamri AH; Bakkari MA; Sabei FY; Safhi AY; Mohammed AM; Hamd MAE; Almawash S
Front Pharmacol; 2023; 14():1025013. PubMed ID: 36825154
[TBL] [Abstract][Full Text] [Related]
7. Novel extraction, rapid assessment and bioavailability improvement of quercetin: A review.
Manzoor MF; Hussain A; Sameen A; Sahar A; Khan S; Siddique R; Aadil RM; Xu B
Ultrason Sonochem; 2021 Oct; 78():105686. PubMed ID: 34358980
[TBL] [Abstract][Full Text] [Related]
8. pH-activated, mitochondria-targeted, and redox-responsive delivery of paclitaxel nanomicelles to overcome drug resistance and suppress metastasis in lung cancer.
Wang H; Shi W; Zeng D; Huang Q; Xie J; Wen H; Li J; Yu X; Qin L; Zhou Y
J Nanobiotechnology; 2021 May; 19(1):152. PubMed ID: 34022909
[TBL] [Abstract][Full Text] [Related]
9. Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer.
Li Y; Zhao Z; Lin CY; Liu Y; Staveley-OCarroll KF; Li G; Cheng K
Theranostics; 2021; 11(5):2182-2200. PubMed ID: 33500719
[No Abstract] [Full Text] [Related]
10. Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research.
Pinto B; Henriques AC; Silva PMA; Bousbaa H
Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33291351
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Characterization of Liposomes Modified with Biosurfactant MEL-A Loading Betulinic Acid and Its Anticancer Effect in HepG2 Cell.
Shu Q; Wu J; Chen Q
Molecules; 2019 Oct; 24(21):. PubMed ID: 31683639
[TBL] [Abstract][Full Text] [Related]
12. Codelivery of doxorubicin and elacridar to target both liver cancer cells and stem cells by polylactide-co-glycolide/d-alpha-tocopherol polyethylene glycol 1000 succinate nanoparticles.
Chen D; Pan X; Xie F; Lu Y; Zou H; Yin C; Zhang Y; Gao J
Int J Nanomedicine; 2018; 13():6855-6870. PubMed ID: 30498347
[TBL] [Abstract][Full Text] [Related]
13. Effect of supersaturation on the oral bioavailability of paclitaxel/polymer amorphous solid dispersion.
Miao L; Liang Y; Pan W; Gou J; Yin T; Zhang Y; He H; Tang X
Drug Deliv Transl Res; 2019 Feb; 9(1):344-356. PubMed ID: 30187352
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles.
Ahmad N; Ahmad R; Alam MA; Ahmad FJ
Chem Cent J; 2018 May; 12(1):65. PubMed ID: 29796830
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration.
Dian LH; Hu YJ; Lin JY; Zhang JY; Yan Y; Cui YN; Su ZB; Lu WL
Int J Nanomedicine; 2018; 13():719-731. PubMed ID: 29440897
[TBL] [Abstract][Full Text] [Related]
16. Aminoglucose-functionalized, redox-responsive polymer nanomicelles for overcoming chemoresistance in lung cancer cells.
Zhou Y; Wen H; Gu L; Fu J; Guo J; Du L; Zhou X; Yu X; Huang Y; Wang H
J Nanobiotechnology; 2017 Nov; 15(1):87. PubMed ID: 29179722
[TBL] [Abstract][Full Text] [Related]
17. Styrene maleic acid-encapsulated paclitaxel micelles: antitumor activity and toxicity studies following oral administration in a murine orthotopic colon cancer model.
Parayath NN; Nehoff H; Norton SE; Highton AJ; Taurin S; Kemp RA; Greish K
Int J Nanomedicine; 2016; 11():3979-91. PubMed ID: 27574427
[TBL] [Abstract][Full Text] [Related]
18. Anti-EGFR-iRGD recombinant protein conjugated silk fibroin nanoparticles for enhanced tumor targeting and antitumor efficiency.
Bian X; Wu P; Sha H; Qian H; Wang Q; Cheng L; Yang Y; Yang M; Liu B
Onco Targets Ther; 2016; 9():3153-62. PubMed ID: 27313461
[TBL] [Abstract][Full Text] [Related]
19. One-step self-assembled nanomicelles for improving the oral bioavailability of nimodipine.
Luo JW; Zhang ZR; Gong T; Fu Y
Int J Nanomedicine; 2016; 11():1051-65. PubMed ID: 27042060
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional targeting vinorelbine plus tetrandrine liposomes for treating brain glioma along with eliminating glioma stem cells.
Li XT; Tang W; Jiang Y; Wang XM; Wang YH; Cheng L; Meng XS
Oncotarget; 2016 Apr; 7(17):24604-22. PubMed ID: 27029055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
